Trials / Conditions / Molybdenum Cofactor Deficiency, Type A
Molybdenum Cofactor Deficiency, Type A
4 registered clinical trials studyying Molybdenum Cofactor Deficiency, Type A — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Enrolling By Invitation | Early Check: Expanded Screening in Newborns NCT03655223 | RTI International | — |
| Completed | Study of ORGN001 (Formerly ALXN1101) in Neonates, Infants and Children With Molybdenum Cofactor Deficiency (MO NCT02629393 | Origin Biosciences | Phase 2 / Phase 3 |
| Completed | Safety & Efficacy Study of ORGN001 (Formerly ALXN1101) in Pediatric Patients With MoCD Type A Currently Treate NCT02047461 | Origin Biosciences | Phase 2 |
| Withdrawn | Study of cPMP (Precusor Z) to Treat Molybdenum Cofactor Deficiency (MoCD) Type A NCT00957749 | Orphatech Pharmaceuticals, GmbH | Phase 1 / Phase 2 |